| Financial Year |
March 31 2023 |
| Monetary Funds |
3,715,258,737.66 |
| Held-for-trading Financial Assets |
242,887,262.42 |
| Notes Receivable |
19,816,998.49 |
| Accounts Receivable |
3,358,954,578.89 |
| Advances to Suppliers |
115,523,950.79 |
| Other Receivables |
208,436,264.12 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
1,386,456.35 |
| Inventories |
2,245,801,262.75 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
32,342,819.57 |
| Other Current Assets |
131,092,547.84 |
| Total Current Assets |
10,245,131,543.79 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
31,353,859.45 |
| Long-term Equity Investment |
498,903,821.13 |
| Investment Properties |
73,976,073.25 |
| Fixed Assetes |
346,459,477.05 |
| Under-construction Projects |
551,596,197.88 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
850,913,247.57 |
| R&D expenses |
114,864,942.09 |
| Goodwill |
3,418,627,427.41 |
| Long-Term Deferred and Prepaid Expenses |
23,162,632.40 |
| Deferred Income Tax Assets |
531,872,649.93 |
| Other Non-Current Assets |
196,807,645.02 |
| Sub-Total of Non-Current Assets |
8,276,738,707.43 |
| Total Assets |
18,521,870,251.22 |
| Short-Term Loans |
665,661,610.36 |
| Trading Financial liabilities |
80,100.00 |
| Notes Payable |
83,337,874.62 |
| Accounts Payable |
2,580,214,653.24 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
79,400,968.02 |
| Taxes Payable |
86,376,430.19 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
118,017,458.98 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
13,814,211.34 |
| Other Current Liabilities |
383,962,604.60 |
| Sub-Total of Current Liabilities |
5,272,774,761.58 |
| Long-term Loans |
300,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
72,835,150.98 |
| Deferred Income Tax Liabilities |
112,788,218.05 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
569,013,680.84 |
| Total Liabilities |
5,841,788,442.42 |
| Paid-In Capital(Or Share Stock) |
1,580,188,215.00 |
| Capital Surplus |
6,268,534,388.55 |
| Surplus Reserve |
85,734,878.92 |
| LESS:Treasury Stock |
167,501,974.48 |
| Undistributed Profits |
4,421,123,425.89 |
| Minority Stockholder's Interest |
500,163,043.89 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
12,179,918,764.91 |
| Owner's Equity（Stockholder's Equity） |
12,680,081,808.80 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
18,521,870,251.22 |
